Quote | Super Quote
25178 JPCLIFE@EP2503A (PUT)
RT Nominal unchange0.025 0.000 (0.000%)

09/10/2024 11:17

{A-shares Focus}CHINA LIFE reached lower price limit

[ET Net News Agency, 9 October 2024] A-shares of CHINA LIFE (SH:601628) fell 10% to
RMB43.56, hitting the lower price limit. It hits an intra-day high of RMB47.9. The total
shares traded was 34.33 million, with a value of RMB1.57b. The volume ratio is 3.1, and
the turnover rate is 0.2%.
H-shares of CHINA LIFE (02628) fell 6.8% to HK$15.16. It hits an intra-day low of HK$15,
and hits an intra-day high of HK$16.96. The total shares traded was 125.28 million, with a
value of HK$2.03b. The active buy/sell ratio is 48:52, with net selling turnover of
HK$56.48m. A-shares of CHINA LIFE has premium of 215.6% over H-shares.(ed)

Remark: Real time quote last updated: 28/11/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.